This protocol addresses vasomotor rhinitis occurring during pregnancy — a situation where effective symptom control must be balanced against maternal and fetal safety at every step of management.
Vasomotor rhinitis in pregnancy responds well to intranasal saline instillation. Beyond saline, drug selection depends on pregnancy safety classification, making agent choice more constrained than in non-pregnant patients.
The protocol centres on intranasal topical therapy for short-term symptom relief. Selection between available agents is guided by pregnancy safety category — the full criteria, sequencing, and alternatives are contained in the complete regimen.
Vasomotor rhinitis in pregnancy responds well to intranasal saline instillation.
Topical decongestants (pregnancy category C) can provide good short-term relief.
View source ↗